UK and US deepen regulatory cooperation on medical devices, building on wider pharmaceutical partnership

UK and US deepen regulatory cooperation on medical devices, building on wider pharmaceutical partnership The Medicines and Healthcare products Regulatory Agency and the US Food and Drug Administration are strengthening cooperation on medical device regulation, to support faster access to safe, innovative technologies for patients in both countries. https://www.gov.uk/government/news/uk-and-us-deepen-regulatory-cooperation-on-medical-devices-building-on-wider-pharmaceutical-partnership?utm_campaign=42504259-FnB%2C%20Cosmetics%2C%20Med%20Dev%2C%20Drugs%20%7C%20Newsfeed%20%7C%20Global%20%7C%202026&utm_medium=email&_hsenc=p2ANqtz-9Q8OYEoIF8A6kq7MqjFsDZSOG8mrV0RJj39nNBluA-NKhFH1c_twjSNbKwrWO3gMQ335bONcizS-nHSmcGZ6QWJK0AIA&_hsmi=416156928&utm_content=416156883&utm_source=hs_email U.S. and U.K. Expand Medical Device Regulatory Cooperation The UK Medicines and Healthcare products Regulatory Agency and the U.S. FDA have announced deeper cooperation on medical device regulation to support faster access to safe, innovative technologies in both countries. The announcement says the agencies will explore ways to improve and align regulatory approaches, including possible future mutual recognition mechanisms intended to reduce duplication and streamline approval processes, while keeping each regulator’s work independent and maintaining safety standards. For medical device companies, this signals a meaningful step toward greater regulatory alignment between two major markets. While this does not change current requirements overnight, it points to a future in which manufacturers may face less duplicative effort and a more coordinated pathway for bringing products to market across the U.S. and U.K.